Amesite Inc(AMST) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 7:44 PM ET (Korea 9/12 08:44)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.65 | Insider Own | 32.94% | Shs Outstand | 4.7M | Perf Week | -2.82% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | 24.05% | Shs Float | 4.4M | Perf Month | 0.49% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | - | Inst Own | 5.99% | Short Float | 0.29% | Perf Quarter | -17.86% |
| Income | -0.00B | P/S | 19.95 | EPS this Y | - | Inst Trans | 8.58% | Short Ratio | 0.12 | Perf Half Y | -39.83% |
| Sales | 0.00B | P/B | 3.77 | EPS next 5Y | - | ROA | -112.3% | Short Interest | 0.01M | Perf YTD | -45.24% |
| Book/sh | 0.27 | P/C | 10.6 | EPS past 3/5Y | 39.67% 19.75% | ROE | -121.49% | 52W High | -78.35% ($4.78) | Perf Year | -73.26% |
| Cash/sh | 0.1 | P/FCF | - | Sales past 3/5Y | -45.88% 13.08% | ROIC | -228.57% | 52W Low | 34.42% ($0.77) | Perf 3Y | -58.27% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 52.42% | Gross Margin | 11.66% | Volatility(W/M) | 5.92% 8.46% | Perf 5Y | -95.73% |
| Dividend TTM | - | EV/Sales | 18.07 | Sales Y/Y TTM | 313.64% | Oper. Margin | -863.74% | ATR (14) | 0.08 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.33 | EPS Q/Q | 10.21% | Profit Margin | -871.86% | RSI (14) | 47.97 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.33 | Sales Q/Q | 171.53% | SMA20 | -0.61% ($1.04) | Beta | 0.99 | Target Price | - |
| Payout | - | Debt/Eq | 0 | Earnings | - | SMA50 | -0.67% ($1.04) | Rel Volume | 0.31 | Prev Close | $1.03 |
| Employees | 8 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -33.87% ($1.56) | Avg Volume(3M) | 0.11M | Price | $1.03 |
| IPO | 2020/9/25 | Option/Short | No/Yes | Trades | 172 | Volume | 32,844 | Change | 0.49% |
Company
AMST is a Technology sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🏥 Amesite (AMST) is a micro-cap technology company that operates an AI-powered learning and healthcare software platform. Originally launched as an edtech business, the company is now pivoting toward healthcare SaaS, centered on NurseMagic, its AI-powered documentation tool for nurses.
Over the past 1 year, on the lower side
78% below its 1-year high.
AMST has weak earning power
Losses or thin margins. Early-stage growth or weakening competitiveness
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Holding long would have lost money
Would have changed by -58.3% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 6.0%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
DFAC 0.00%
DFSU 0.00%
VXF 0.00%It ranks #4 in the industry
Based on market cap of $7M.
AMST $7M PER -
SAP $238B PER 25.9
CRM $204B PER 22.6
SHOP $166B PER 86.8
FAQ
What kind of company is AMST?
AMST belongs to the Technology sector and operates in the Software - Application industry.
What is the market cap of AMST?
The market cap of AMST is approximately $7M, ranking 5,611 within its sector.
What is the 52-week high and low for AMST?
AMST has recorded a 52-week high of $4.78 and a low of $0.77.
